Literature DB >> 23363035

Disturbed sleep in Parkinson's disease: anatomical and pathological correlates.

M E Kalaitzakis1, S M Gentleman, R K B Pearce.   

Abstract

AIMS: Abnormal sleep is a common feature of Parkinson's disease (PD) and prodromal disorders of sleep are frequent (e.g. restless legs syndrome and rapid eye movement sleep behaviour disorder). However, the exact pathological basis of disturbed sleep remains as yet undefined.
METHODS: To investigate this further, 32 PD cases were stratified into three groups: (1) PD with disturbed sleep, PD(S); (2) PD with dementia (PDD) and disturbed sleep, PDD(S); and (3) PD without disturbed sleep, PD(nS). The extent of α-synuclein (αSyn) and Alzheimer disease (AD)-type pathology [amyloid β peptide (Aβ) and tau] was assessed in 15 regions of the PD brain.
RESULTS: The results demonstrate a significant association between disturbed sleep in PD and αSyn pathology in specific brainstem [locus coeruleus (P = 0.006) and raphe nuclei (P = 0.02)], hypothalamic [paramammillary nuclei (P = 0.04) and posterior nucleus (P = 0.02)], subcortical/limbic [amygdala (P = 0.03), thalamus (P = 0.01)] and cortical [entorhinal cortex (P = 0.01)] regions. A statistically significant increase of tau pathology was observed in the amygdala (P = 0.03), CA2 sector of the hippocampus (P = 0.01) and entorhinal cortex (P = 0.04) in PD cases with disturbed sleep.
CONCLUSIONS: Pathological changes in these structures, residing in the brain circuitry relating to sleep physiology, strongly predict the presence of sleep disturbances in PD.
© 2013 British Neuropathological Society.

Entities:  

Keywords:  Lewy body disease; Parkinson's disease; dementia; neuropathology; sleep

Mesh:

Substances:

Year:  2013        PMID: 23363035     DOI: 10.1111/nan.12024

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  20 in total

Review 1.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

2.  Basal ganglia beta oscillations during sleep underlie Parkinsonian insomnia.

Authors:  Aviv D Mizrahi-Kliger; Alexander Kaplan; Zvi Israel; Marc Deffains; Hagai Bergman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-07       Impact factor: 11.205

Review 3.  Sleep Disturbances in the Prodromal Stage of Parkinson Disease.

Authors:  Ahmed Al-Qassabi; Seyed-Mohammad Fereshtehnejad; Ronald B Postuma
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

4.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

Review 5.  Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.

Authors:  Reyisha Taximaimaiti; Xingguang Luo; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

6.  Relationship between Sleep Quality and Cognitive Function in Patients with Mild-to-Moderate Parkinson's Disease.

Authors:  Hui-Miao Liu; Miao Chu; Na Li; Sai Zhang; Yong-Zhi Zhang; Ping Gu
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

Review 7.  Approach to Cognitive Impairment in Parkinson's Disease.

Authors:  Qiang Zhang; Georgina M Aldridge; Nandakumar S Narayanan; Steven W Anderson; Ergun Y Uc
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 6.088

8.  A Polysomnographic Study of Parkinson's Disease Sleep Architecture.

Authors:  Daniel Martinez-Ramirez; Sol De Jesus; Roger Walz; Amin Cervantes-Arriaga; Zhongxing Peng-Chen; Michael S Okun; Vanessa Alatriste-Booth; Mayela Rodríguez-Violante
Journal:  Parkinsons Dis       Date:  2015-10-04

Review 9.  Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Authors:  Miguel Rosa-Grilo; Mubasher A Qamar; Raquel N Taddei; Javier Pagonabarraga; Jaime Kulisevsky; Anna Sauerbier; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2017-09-05

Review 10.  α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.

Authors:  Laura M Butkovich; Madelyn C Houser; Malú G Tansey
Journal:  Front Neurosci       Date:  2018-09-11       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.